Metformin Shows Promise for Better Surgical Recovery in Older Adults
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
20 articles
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.
University of Pennsylvania researchers investigated how insulin resistance and testosterone interact in women after menopause.
Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
Major prevention trial proves diet and exercise dramatically reduce diabetes onset compared to medication alone.
Major trial of 10,251 diabetics reveals surprising outcomes from aggressive blood sugar, blood pressure, and cholesterol management.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Takeda's Phase 1 trial evaluates the safety and tolerability of TAK-510, a novel injectable agent targeting nausea and vomiting, across escalating doses.
Small study tests whether combining Mediterranean eating, intermittent fasting, and exercise can reverse diabetes in 6 months.